Efficacy and Safety of Ciclesonide (CIC) Administered Twice Daily in Pediatric Patients With Asthma.
Clinical trial NCT00392288 · COMPLETED
Trial details
- NCT number
- NCT00392288
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2008-02-01
- Enrollment
- 528
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.